Clinical Trial Update: A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors [Phase 1]

View source ↗

Summary

Clinical trial update detailing a Phase 1 safety study of GEN1042 in Japanese subjects with malignant solid tumors, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor

Drugs mentioned

• GEN1042

Snippet

Sponsor: Genmab | Conditions: Malignant Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING